Janssen COVID-19 Vaccine No Longer Available in U.S.

The U.S. Food and Drug Administration (CDC) confirmed on June 2, 2023, that the agency had revoked the emergency use authorization (EUA) of the Janssen COVID-19 Vaccine known as Jcovden®.

On May 22, 2023, Janssen Biotech Inc. requested the voluntary withdrawal of the EUA for this vaccine.

Previously, Janssen informed the FDA that the last lots of the vaccine purchased by the U.S. Government had expired, there is no demand for new lots of the vaccine in the U.S., and they do not intend to update the strain composition of this vaccine to address emerging variants.

On February 27, 2021, Johnson & Johnson announced that the FDA issued an EUA for this recombinant, replication-incompetent adenovirus, non-mRNA COVID-19 vaccine.

As of June 4, 2023, the authorization or approval status of the Jcovden COVID-19 vaccine varies by country.